UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting

Diagnostics (Basel), 2021-11, Vol.11 (12), p.2236

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study

Hepatology (Baltimore, Md.), 2017-04, Vol.65 (4), p.1293-1305

2017

Link zum Volltext

Verfügbarkeit prüfen

Use of chronic medications and risk of death due to COVID-19 in hospitalised patients

European journal of hospital pharmacy. Science and practice, 2024-05, Vol.31 (3), p.247

2024

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study

Hepatology (Baltimore, Md.), 2016-12, Vol.64 (6), p.2173-2184

2016

Link zum Volltext

Verfügbarkeit prüfen

Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis

Hepatology (Baltimore, Md.), 2018-04, Vol.67 (4), p.1485-1498

2018

Link zum Volltext

Verfügbarkeit prüfen

Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding

Clinical gastroenterology and hepatology, 2018-01, Vol.16 (1), p.132-139.e8

2018

Link zum Volltext

Verfügbarkeit prüfen

Morbilidad metabólica en la población penitenciaria de Cataluña

Atención primaria, 2023-06, Vol.55 (6), p.102620, Article 102620

2023

Link zum Volltext

Verfügbarkeit prüfen

AEEH «Consensus about detection and referral of hidden prevalent liver diseases

Gastroenterología y hepatología, 2023-03, Vol.46 (3), p.236-247

2023

Link zum Volltext

Verfügbarkeit prüfen

The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease

Life (Basel, Switzerland), 2023-02, Vol.13 (2), p.419

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology

Liver international, 2022-08, Vol.42 (8), p.1783-1792

2022

Link zum Volltext

Verfügbarkeit prüfen

Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals

Therapeutic advances in gastroenterology, 2017-08, Vol.10 (8), p.619-629

2017

Link zum Volltext

Verfügbarkeit prüfen

Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH

Disease models & mechanisms, 2021-05, Vol.14 (5)

2021

Link zum Volltext

Verfügbarkeit prüfen

Overall clinical and economic impact of non-alcoholic fatty liver disease

Revista española de enfermedades digestivas, 2021-06, Vol.113 (6), p.396-403

2021

Link zum Volltext

Verfügbarkeit prüfen

Predicting Early Mortality After Acute Variceal Hemorrhage Based on Classification and Regression Tree Analysis

Clinical gastroenterology and hepatology, 2009-12, Vol.7 (12), p.1347-1354

2009

Link zum Volltext

Verfügbarkeit prüfen

Acute esophageal variceal bleeding:Current strategies and new perspectives

World journal of hepatology, 2010-07, Vol.2 (7), p.261-274

2010

Link zum Volltext

Verfügbarkeit prüfen

Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease

Obesity surgery, 2018-01, Vol.28 (1), p.142-151

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study

Journal of clinical medicine, 2023-11, Vol.12 (23), p.7276

2023

Link zum Volltext

Verfügbarkeit prüfen

A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo

Biomedicines, 2022-05, Vol.10 (5), p.1191

2022

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25)

Journal of hepatology, 2020-09, Vol.73 (3), p.740-741

2020

Link zum Volltext

Verfügbarkeit prüfen

Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD

Journal of clinical medicine, 2022-04, Vol.11 (9), p.2466

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis

Biomedicines, 2022-04, Vol.10 (5), p.1015

2022

Link zum Volltext

Verfügbarkeit prüfen

Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas

Gastroenterología y hepatología, 2023-03, Vol.46 (3), p.236-247

2023

Link zum Volltext

Verfügbarkeit prüfen

High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study

Hepatology communications, 2022-11, Vol.6 (11), p.3212-3222

2022

Link zum Volltext

Verfügbarkeit prüfen

Complications in the Immediate Postoperatory of Lung Transplantation: Three Years of Practice at a High-Experienced Center

Chest, 2014-03, Vol.145 (3), p.631A-1-631A-2

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Englisch
(138)
Japanisch
(10)
Spanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting

Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study

Use of chronic medications and risk of death due to COVID-19 in hospitalised patients

Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study

Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis

Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding

Morbilidad metabólica en la población penitenciaria de Cataluña

AEEH «Consensus about detection and referral of hidden prevalent liver diseases

The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology

Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals

Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH

Overall clinical and economic impact of non-alcoholic fatty liver disease

Predicting Early Mortality After Acute Variceal Hemorrhage Based on Classification and Regression Tree Analysis

Acute esophageal variceal bleeding:Current strategies and new perspectives

Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease

Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study

A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo

Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25)

Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD

Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis

Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas

High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study

Complications in the Immediate Postoperatory of Lung Transplantation: Three Years of Practice at a High-Experienced Center

Suchergebnisse filtern